Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-17

FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)

View source ↗

Summary

FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) submitted by Voyant Beauty Inc. The approval documents the status of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAMISIL AT CREAM (TERBINAFINE HYDROCHLORIDE)

Snippet

SUPPL AP for LAMISIL AT CREAM (TERBINAFINE HYDROCHLORIDE)